These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 22740072)
1. Effects of ibutilide on canine cardiac pacing threshold and on induction rates of atrial fibrillation. Sun JL; Han R; Guo JH; Li XY; Ma XL; Wang CY Cell Biochem Biophys; 2012 Dec; 64(3):197-203. PubMed ID: 22740072 [TBL] [Abstract][Full Text] [Related]
3. High-density mapping of pulmonary veins and left atrium during ibutilide administration in a canine model of sustained atrial fibrillation. Chou CC; Zhou S; Tan AY; Hayashi H; Nihei M; Chen PS Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2704-13. PubMed ID: 16055519 [TBL] [Abstract][Full Text] [Related]
4. Hybrid therapy of atrial fibrillation. Santini M; Pignalberi C; Ricci R; Calò L Ital Heart J; 2002 Oct; 3(10):571-8. PubMed ID: 12478814 [TBL] [Abstract][Full Text] [Related]
5. [The study of inhibiting heart rate and rapidly terminating atrial flutter of ibutilide on canine]. Sun JL; Li XY; Guo JH; Liu P; Zhang P; Yi Z Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Oct; 37(10):920-4. PubMed ID: 20137545 [TBL] [Abstract][Full Text] [Related]
6. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study. Bernard EO; Schmid ER; Schmidlin D; Scharf C; Candinas R; Germann R Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468 [TBL] [Abstract][Full Text] [Related]
7. Prevention of acute inducible atrial flutter in dogs by using an ibutilide-polymer-coated pacing electrode. Labhasetwar V; Strickberger SA; Underwood T; Davis J; Levy RJ J Cardiovasc Pharmacol; 1998 Mar; 31(3):449-55. PubMed ID: 9514191 [TBL] [Abstract][Full Text] [Related]
8. [Inhibition of the muscarinic potassium current by KB130015, a new antiarrhythmic agent to treat atrial fibrillation]. Borchard R; van Bracht M; Wickenbrock I; Prull MW; Pott L; Trappe HJ Med Klin (Munich); 2005 Nov; 100(11):697-703. PubMed ID: 16328176 [TBL] [Abstract][Full Text] [Related]
9. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease. Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects on drug concentrations, electrophysiologic parameters, and termination of atrial fibrillation in dogs when procainamide and ibutilide are delivered into the right atrium versus intravenously. Vereckei A; Warman E; Mehra R; Zipes DP J Cardiovasc Electrophysiol; 2001 Mar; 12(3):330-6. PubMed ID: 11291807 [TBL] [Abstract][Full Text] [Related]
11. "Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Blaauw Y; Gögelein H; Tieleman RG; van Hunnik A; Schotten U; Allessie MA Circulation; 2004 Sep; 110(13):1717-24. PubMed ID: 15364815 [TBL] [Abstract][Full Text] [Related]
12. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm. Zarkin GA; Bala MV; Calingaert B; VanderLugt JT Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487 [TBL] [Abstract][Full Text] [Related]
13. Effects of ibutilide on inhibiting heart rate and rapidly terminating atrial flutter in canine. Sun J; Li X; Guo J; Liu P; Zhang P Cell Biochem Biophys; 2011 Apr; 59(3):153-8. PubMed ID: 20972643 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic enhancement of atrial electrical defibrillation efficacy: role of ibutilide. Khoury DS; Assar MD; Sun H J Interv Card Electrophysiol; 1997 Dec; 1(4):291-8. PubMed ID: 9869983 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of ibutilide in cardioversion of persistent atrial fibrillation in patients with dual chamber stimulation. Santini M; Pignalberi C; Ricci R; Calò L; Santini L J Interv Card Electrophysiol; 2003 Aug; 9(1):15-20. PubMed ID: 12975565 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation. Nair M; George LK; Koshy SK J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348 [TBL] [Abstract][Full Text] [Related]
17. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation. Hou Y; Fang PH; Liu J; Li XF; Hu JQ; Zhang S Chin Med J (Engl); 2011 Mar; 124(5):710-3. PubMed ID: 21518563 [TBL] [Abstract][Full Text] [Related]
18. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model. Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442 [TBL] [Abstract][Full Text] [Related]
19. Effects of verapamil and ibutilide on atrial fibrillation and postfibrillation atrial refractoriness. Sticherling C; Hsu W; Tada H; Bares AC; Oral H; Pelosi F; Knight BP; Strickberger SA; Morady F J Cardiovasc Electrophysiol; 2002 Feb; 13(2):151-7. PubMed ID: 11900290 [TBL] [Abstract][Full Text] [Related]
20. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed. Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]